Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc (ORGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Organogenesis Holdings Inc. (ORGO) Q3 2022 Earnings Call Transcript Motley Fool - Wed Nov 9, 9:00PM CST

ORGO earnings call for the period ending September 30, 2022.

ORGO : 2.64 (-5.04%)
Organogenesis (ORGO) Lags Q3 Earnings and Revenue Estimates Zacks - Wed Nov 9, 4:45PM CST

Organogenesis (ORGO) delivered earnings and revenue surprises of -33.33% and 3.74%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ORGO : 2.64 (-5.04%)
TXMD : 4.23 (-5.16%)
Akebia Therapeutics (AKBA) Reports Q3 Loss, Tops Revenue Estimates Zacks - Thu Nov 3, 5:45PM CDT

Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -86.67% and 3.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

AKBA : 0.2509 (-1.99%)
ORGO : 2.64 (-5.04%)
Why Organogenesis Stock Is Tumbling Today Motley Fool - Wed Aug 10, 2:40PM CDT

It didn't make as much money in the second quarter as investors were hoping.

ORGO : 2.64 (-5.04%)
Organogenesis Holdings Inc. (ORGO) Q2 2022 Earnings Call Transcript Motley Fool - Wed Aug 10, 9:30AM CDT

ORGO earnings call for the period ending June 30, 2022.

ORGO : 2.64 (-5.04%)
Organogenesis (ORGO) Tops Q2 Earnings and Revenue Estimates Zacks - Tue Aug 9, 5:25PM CDT

Organogenesis (ORGO) delivered earnings and revenue surprises of 12.50% and 0.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ORGO : 2.64 (-5.04%)
ATNM : 10.97 (-0.27%)
Organogenesis Holdings Inc. Reports Second Quarter 2022 Financial Results Globe Newswire - Tue Aug 9, 3:05PM CDT

CANTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the...

ORGO : 2.64 (-5.04%)
Select Medical (SEM) Misses Q2 Earnings and Revenue Estimates Zacks - Thu Aug 4, 7:45PM CDT

Select Medical (SEM) delivered earnings and revenue surprises of -15.69% and 1.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SEM : 23.43 (-3.34%)
ORGO : 2.64 (-5.04%)
Organogenesis (ORGO) Stock Jumps 5.3%: Will It Continue to Soar? Zacks - Wed Jul 13, 6:44AM CDT

Organogenesis (ORGO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

ORGO : 2.64 (-5.04%)
OPTN : 1.7500 (-6.91%)
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2022 Financial Results on August 9, 2022 Globe Newswire - Thu Jun 30, 6:30AM CDT

CANTON, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the...

ORGO : 2.64 (-5.04%)

Barchart Exclusives

Trading Pressure Can Impact a Trader's Performance Barchart - Mon Nov 28, 4:34PM CST
Trading pressure has been going on for so long that we feel there is no way to eliminate it, but we can successfully react to it in many ways. We, as traders, tend to put ourselves in pressure situations frequently. I want to help you recognize these potential pressure situations and prepare you well ahead when they occur. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' : 'America/Chicago' ]] CT
Reserve Your Spot